% | $
Quotes you view appear here for quick access.

Neostem, Inc. Message Board

  • want2movesouth want2movesouth Mar 17, 2013 5:00 PM Flag

    3 Biotech Stocks That Are Set-Up Nicely For Growth

    The real big news for NBS was an analyst research report from Brinson Patrick Securities as they initiated coverage with a market outperform rating and established a $6.00 price target for the company. Fundamentals have been improving each of the last several quarters and the revenue growth from PCT has kept the balance sheet strong.

2.250.00(0.00%)Jun 5 3:59 PMEDT